| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 04/17/1997 | WO1997013517A1 Aqueous eye drops containing apafant as principal agent |
| 04/17/1997 | WO1997013506A1 η-RAR ANTAGONIST LIGAND OR α-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR |
| 04/17/1997 | WO1997005862A3 Use of basic amino acids and derivatives for lowering ceramide levels |
| 04/17/1997 | CA2599488A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 04/16/1997 | EP0768086A1 Treatment of tinnitus using neuroprotective agents |
| 04/16/1997 | EP0767777A1 New salts of 2- (2,6-dichlorophenyl)amine]phenylacetoxyacetic acid with organic basic cations |
| 04/16/1997 | EP0767672A1 Use of copolymer-1 for the manufacture of a medicament for the treatment of optic neuritis |
| 04/16/1997 | CN1147520A 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 04/16/1997 | CN1147406A Cockscomb beverage |
| 04/15/1997 | US5620998 Cardiovascular disorders; hypotensive agents |
| 04/15/1997 | US5620990 Alpha-(4-chlorophenyl)-4-[(4-fluorphenyl)-methyl]piperidine-1-ethanol esters, their preparation and their therapeutic application |
| 04/15/1997 | US5620966 11,21-bisphenyl-19-norpregnane derivatives |
| 04/15/1997 | US5620921 Treating keratoconjunctivitis sicca by topical application of androgen to ocular surface or immediate vicinity of eye |
| 04/15/1997 | US5620699 Method for delivering nonaqueous fluorinated drug delivery vehicle suspensions |
| 04/10/1997 | WO1997012902A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/10/1997 | WO1997012874A1 Imidazole derivatives having affinity for alpha2 receptors activity |
| 04/10/1997 | WO1997012853A1 Dimer-selective rxr modulators and methods for their use |
| 04/10/1997 | WO1997012852A1 Semi-fluorinated alkanes and their use |
| 04/10/1997 | WO1997012616A1 Drug for treating glaucoma |
| 04/10/1997 | WO1997002830A3 Use of indigestible oligosaccharides to treat and prevent otitis media in humans |
| 04/10/1997 | CA2233888A1 Dimer-selective rxr modulators and methods for their use |
| 04/10/1997 | CA2229434A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/09/1997 | EP0767170A1 Novel 4,6-diarylpyrimidine derivatives and salts thereof |
| 04/09/1997 | EP0767167A1 Trifluoromethylsulfonylphenyl or trifluoromethylsulfinylphenyl group containing 2-cyano-3-hydroxy-propenamide derivatives, process for their preparation, their use as medicaments and pharmaceutical compositions containing them |
| 04/09/1997 | EP0766696A1 Thiazolidine derivatives, their preparation and drugs containing same |
| 04/09/1997 | EP0766695A1 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
| 04/09/1997 | EP0766684A1 Endothelin receptor antagonists |
| 04/09/1997 | EP0766672A1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 04/09/1997 | EP0766665A2 Metalloproteinase inhibitors |
| 04/09/1997 | EP0766664A2 Metalloproteinase inhibitors |
| 04/09/1997 | EP0651739B1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 04/09/1997 | CN1147260A Neurokinine (tachykinine) antagonists |
| 04/09/1997 | CN1034503C Pyrazolopyrimidinone antianginal agent preparing process |
| 04/08/1997 | US5618844 Matrix metalloproteinase inhibitor |
| 04/08/1997 | US5618825 Combinatorial sulfonamide library |
| 04/08/1997 | US5618812 Benzodiazepine derivatives |
| 04/08/1997 | US5618553 Contacting localized region of eye with polymer implant having reversibly associated modulating agent which is released at rate such that target cells are primarily affected |
| 04/03/1997 | WO1997011960A1 Antagonists of endothelin receptors |
| 04/03/1997 | WO1997011655A1 Implantable controlled release device to deliver drugs directly to an internal portion of the body |
| 04/02/1997 | EP0765666A1 Inhibition of irregular binding of lens cells |
| 04/02/1997 | EP0765305A1 Anti-inflammatory compounds |
| 04/02/1997 | EP0765169A1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
| 04/02/1997 | CN1146346A Yanming bag-soaking oral preparation for eye health care and making method |
| 04/01/1997 | US5616596 Substituted arylalkynyl-and heteroarylalkynl-N-hydroxyurea inhibitors of leukotriene biosynthesis |
| 04/01/1997 | CA1339031C Method of preserving ophthalmic solutions and compositions therefor |
| 03/27/1997 | WO1997010805A1 Ophthalmic compositions containing cyclodextrins and quaternary ammonium compounds |
| 03/27/1997 | WO1996029974A3 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 03/26/1997 | EP0764637A2 2-Cyano-3-mercaptocrotonamides |
| 03/26/1997 | EP0764163A1 Tachykinin (nk 1) receptor antagonists |
| 03/26/1997 | EP0764018A1 Non-steroidal anti-inflammatory ophthalmic suspensions |
| 03/26/1997 | CN1146208A Peptides as therapeutic agents for treatment of auto-immune diseases |
| 03/26/1997 | CN1146155A Method for implanting encapsulated cells in a host |
| 03/26/1997 | CN1145908A New aminophenylphosphonic acid compounds, process for preparing them and pharmaceutical compositions containing them |
| 03/26/1997 | CN1145895A New amido-ethyl substituted fluorene compound and its prepn. |
| 03/25/1997 | CA2139109C Purinone antianginal agents |
| 03/20/1997 | WO1997010216A1 Substituted hydroisoquinoline derivatives and their use as pharmaceuticals |
| 03/20/1997 | WO1997009981A1 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 03/20/1997 | CA2185850A1 2-cyano-3-mercaptocrotonamides |
| 03/19/1997 | EP0763541A1 11-(Substituted phenyl)-estra-4,9-diene derivatives |
| 03/19/1997 | EP0763359A1 Pharmaceutical composition for topical use |
| 03/19/1997 | EP0763016A1 Compositions and methods for treating mast-cell mediated conditions |
| 03/19/1997 | EP0763012A1 Succinyl hydroxamic acid, n-formyl-n-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors |
| 03/19/1997 | EP0634998B1 Hydroxamic acid based collagenase and cytokine inhibitors |
| 03/19/1997 | CN1145636A Vascular endothelial growth factor 2 |
| 03/19/1997 | CN1145364A Heterocyclic compounds and their preparation and use |
| 03/18/1997 | US5612360 Aromatic n-heterocyclic compounds as hypotensive agents with acid groups, sulfonylcarboxamides or tetrazole groups |
| 03/18/1997 | US5612359 Substituted biphenyl isoxazole sulfonamides |
| 03/18/1997 | US5612027 Eye surgery and maintaining pupil size by administering an acidic viscoelastic polymer |
| 03/18/1997 | US5611464 Container for preserving media in the tip of a solution dispenser |
| 03/13/1997 | WO1997009311A1 New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
| 03/13/1997 | WO1997009049A2 Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives |
| 03/13/1997 | WO1997009042A1 Pharmaceutical formulation |
| 03/13/1997 | CA2230687A1 Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives |
| 03/12/1997 | EP0761217A1 Ready-to-use eye lotion containing indomethacin |
| 03/12/1997 | EP0760811A1 Imidazole derivatives as histamine receptor h 3? (ant)agonists |
| 03/12/1997 | EP0760663A1 Use of a 2-(4-(azolylbutyl)-piperazinyl-methyl)-benzimidazole derivative for treating allergic conjunctivitis |
| 03/12/1997 | CN1145075A Antagonist's of endothelin receptors |
| 03/11/1997 | US5610176 Tachykinin (NK1) receptor antagonists |
| 03/06/1997 | WO1997008166A1 Piperazino derivatives as neurokinin antagonists |
| 03/05/1997 | EP0759773A1 Lacrimal gland specific emulsions for topical application to ocular tissue |
| 03/05/1997 | EP0759756A1 Pharmaceutical composition for treating glaucoma containing terazosin |
| 03/05/1997 | EP0504207B1 Peptide derivative, process for the preparation thereof, pharmaceutical preparation containing it |
| 03/05/1997 | CN1144477A Ophthalmic composition with decreased viscosity |
| 03/05/1997 | CN1144476A Ophthalmic composition containing ion sensitive, hydrophilic polymer and inorganic salt in ratio which gives low viscosity |
| 03/05/1997 | CN1144091A Compounds having retinoid-like activity |
| 03/05/1997 | CN1034171C 4-pyrimdinone derivatives, their preparation and their application in therapy |
| 03/04/1997 | US5607978 Prostaglandins for vision defects |
| 03/04/1997 | US5607967 Treatment of alzheimer's disease with 5-(tetradecyloxy)-2-furan carboxylic acid |
| 02/27/1997 | WO1997007198A2 Dna sequences and secreted proteins encoded thereby |
| 02/27/1997 | WO1997007115A1 Benzenesulphonamide derivatives as bradykinine antagonists |
| 02/27/1997 | WO1997006791A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF αvβ5 MEDIATED ANGIOGENESIS |
| 02/27/1997 | WO1997003188A3 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 02/27/1997 | WO1997001579A3 Somatostatin peptides |
| 02/27/1997 | WO1996022095A3 Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts |
| 02/27/1997 | CA2229208A1 Dna sequences and secreted proteins encoded thereby |
| 02/26/1997 | EP0759295A1 Use of adamantan derivatives for the treatment of internal ear diseases |
| 02/26/1997 | EP0759067A1 Transforming growth factor alpha h1 |
| 02/26/1997 | EP0758899A1 Permeabilizer peptides for increasing blood-ocular barrier permeability |
| 02/26/1997 | EP0726911A4 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf |
| 02/26/1997 | EP0705266B1 Process for producing imidazole derivative |